GPR161-EFTUD1 Fusion FISH Probe
The GPR161-EFTUD1 Fusion FISH Probe is used to confirm a fusion of the GPR161 and EFTUD1 genes. The fusion of the GPR161 and EFTUD1 genes has been associated with Sarcoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| GPR161-EFTUD1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| GPR161-EFTUD1-20-AQAQ | 20 (40 μL) | 200 μL |
|
GPR161 Gene Summary
The protein encoded by this gene is an orphan G protein-coupled receptor whose ligand is unknown. This gene is overexpressed in triple-negative breast cancer, and disruption of this gene slows the proliferation of basal breast cancer cells. Therefore, this gene is a potential drug target for triple-negative breast cancer. [provided by RefSeq, Mar 2017]
Gene Name: G Protein-coupled Receptor 161
Chromosome: CHR1: 168053996 -168105624
Locus: 1q24.2
Gene Diseases
The GPR161 EFTUD1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Sarcoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|